Advanced search
Publication Cover
Infection and Drug Resistance Volume 14, 2021 - Issue
Submit an article Journal homepage
250
Views
8
CrossRef citations to date
0
Altmetric
Original Research

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China

Xia Yu1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Fengmin Huo1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Fen Wang1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Shu’an Wen1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Guanglu Jiang1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Yi Xue1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Lingling Dong1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Liping Zhao1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Rui Zhu1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of China
&
Hairong Huang1 National Clinical Laboratory on Tuberculosis, Beijing Key Laboratory for Drug-Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 4689-4697 | Published online: 09 Nov 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ruixian Zhang, Sha Luo, Nan Wang, Hongying Zhang & Xuping Wu. (2023) Epidemiology of Nontuberculous Mycobacteria in Nanjing and MAB_0540 Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus. Infection and Drug Resistance 16, pages 2751-2764.
Read now

Articles from other publishers (7)

Anqi Li, Zhili Tan, Siyuan He & Haiqing Chu. (2023) In vitro susceptibility testing of tetracycline‐class antibiotics against slowly growing non‐tuberculous mycobacteria. Clinical and Experimental Pharmacology and Physiology 50:7, pages 604-609.
Crossref
Huiwen ZhengYiting WangWencong HeFeina LiHui XiaJing XiaoXichao OuShengfen WangChen ShenYanlin Zhao. (2023) Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China . Microbial Drug Resistance 29:3, pages 112-114.
Crossref
Shuo Yuan, Dan-Dan Shen, Yi-Ru Bai, Miao Zhang, Tian Zhou, Chong Sun, Li Zhou, Sai-Qi Wang & Hong-Min Liu. (2023) Oxazolidinone: A promising scaffold for the development of antibacterial drugs. European Journal of Medicinal Chemistry 250, pages 115239.
Crossref
Chungen Li, Xirong Tian, Zongkai Huang, Xupeng Gou, Buhari Yusuf, Cong Li, Yamin Gao, Song Liu, Yanmei Wang, Tao Yang, Zhiyong Liu, Qingxiang Sun, Tianyu Zhang & Youfu Luo. (2023) Structure–Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis . Journal of Medicinal Chemistry 66:4, pages 2699-2716.
Crossref
Danila Zimenkov. (2022) Variability of Mycobacterium avium Complex Isolates Drug Susceptibility Testing by Broth Microdilution. Antibiotics 11:12, pages 1756.
Crossref
Brett D. Edwards & Stephen K. Field. (2022) The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis. Drugs 82:18, pages 1695-1715.
Crossref
Andreea-Daniela Meca, Liliana Mititelu-Tarțău, Maria Bogdan, Lorena Anda Dijmarescu, Ana-Maria Pelin & Liliana Georgeta Foia. (2022) Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae. Journal of Personalized Medicine 12:4, pages 569.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.